Strategy | Financing Highlight Private Placement / Financing Transactions Immutics: The company raised $100 million of venture funding from undisclosed investors on July 6, 2022. The company is a developer of antibody drugs intended for applications in Immuno oncology...
Strategy | Financing Highlight Private Placement / Financing Transactions AmplifyBio: The company raised $100 million of venture funding from undisclosed investors on June 27, 2022. The company is an operator of a biotechnology platform intended to advance the quality...
Private Placement / Financing Transactions Ablative Solutions: The company raised $91.4 million through a combination of Series D1 and Series D2 venture funding in a deal led by BioStar Capital and Gilde Healthcare Partners on June 13, 2022, putting the...
Strategy | Financing Highlight Private Placement / Financing Transactions Owkin: The company raised $80 million of Series B1 venture funding in a deal led by Bristol-Myers Squibb on June 9, 2022. The company is a developer of machine learning tools designed to augment...
Strategy | Financing Highlight Private Placement / Financing Transactions Diabeloop: The company raised EUR 70 million of Series C venture funding in a deal led by LBO France on June 2, 2022, putting the company’s pre-money valuation at an estimated EUR 253.34...
Strategy | Financing Highlight Private Placement / Financing Transactions ProFound Therapeutics: The company raised $75 million of venture funding from Flagship Pioneering on May 26, 2022. The company is a developer of a platform intended to discover expanded human...
